Page 2 - Nasdaq Repl News Today

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients...

Shares of Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) hit a new 52-week low on Thursday . The stock traded as low as $13.34 and last traded at $13.34, with a volume of 529686 shares traded. The stock had previously closed at $14.29. Analyst Ratings Changes Separately, HC Wainwright reduced their price objective on […]

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report)’s stock price reached a new 52-week low during trading on Monday . The stock traded as low as $15.33 and last traded at $15.41, with a volume of 25155 shares traded. The stock had previously closed at $16.17. Analyst Ratings Changes Separately, HC Wainwright dropped their target […]

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) was the target of some unusual options trading on Wednesday. Stock traders purchased 2,604 put options on the company. This represents an increase of 110% compared to the average volume of 1,239 put options. Replimune Group Stock Performance REPL traded down $0.25 during trading on Wednesday, hitting […]

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) shares traded down 3.2% during trading on Friday . The stock traded as low as $15.93 and last traded at $15.98. 125,998 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 563,938 shares. The stock had previously closed at $16.50. […]

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) was down 4.2% during trading on Wednesday . The company traded as low as $17.01 and last traded at $17.08. Approximately 315,762 shares changed hands during mid-day trading, a decline of 44% from the average daily volume of 563,851 shares. The stock had previously closed at $17.83. […]

Panagora Asset Management Inc. raised its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 0.8% during the first quarter, according to its most recent filing with the SEC. The firm owned 67,890 shares of the company’s stock after purchasing an additional 568 shares during the period. Panagora Asset Management Inc. owned […]

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) insider Pamela Esposito sold 1,400 shares of Replimune Group stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $20.00, for a total value of $28,000.00. Following the sale, the insider now directly owns 263,436 shares of the company’s stock, […]

Integral Health Asset Management LLC increased its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 79.5% during the 1st quarter, Holdings Channel.com reports. The fund owned 395,000 shares of the company’s stock after acquiring an additional 175,000 shares during the period. Integral Health Asset Management LLC’s holdings in Replimune Group were […]

Integral Health Asset Management LLC lifted its stake in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 79.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 395,000 shares of the company’s stock after acquiring an additional 175,000 shares during the […]